- Home
- MCVT vs TLPH Comparison
MCVT vs TLPH Comparison
Compare MCVT & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- TLPH
- Stock Information
- Founded
- MCVT 2007
- TLPH 2005
- Country
- MCVT United States
- TLPH United States
- Employees
- MCVT N/A
- TLPH N/A
- Industry
- MCVT Finance Companies
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- MCVT Finance
- TLPH Health Care
- Exchange
- MCVT Nasdaq
- TLPH Nasdaq
- Market Cap
- MCVT 9.3M
- TLPH 10.6M
- IPO Year
- MCVT N/A
- TLPH 2011
- Fundamental
- Price
- MCVT $1.85
- TLPH $0.45
- Analyst Decision
- MCVT
- TLPH Strong Buy
- Analyst Count
- MCVT 0
- TLPH 1
- Target Price
- MCVT N/A
- TLPH $6.00
- AVG Volume (30 Days)
- MCVT 16.3K
- TLPH 42.9K
- Earning Date
- MCVT 08-13-2025
- TLPH 08-13-2025
- Dividend Yield
- MCVT N/A
- TLPH N/A
- EPS Growth
- MCVT N/A
- TLPH N/A
- EPS
- MCVT 0.19
- TLPH N/A
- Revenue
- MCVT $3,246,479.00
- TLPH $27,000.00
- Revenue This Year
- MCVT N/A
- TLPH N/A
- Revenue Next Year
- MCVT N/A
- TLPH $14,533.26
- P/E Ratio
- MCVT $9.60
- TLPH N/A
- Revenue Growth
- MCVT N/A
- TLPH N/A
- 52 Week Low
- MCVT $1.13
- TLPH $0.43
- 52 Week High
- MCVT $3.88
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- MCVT 48.82
- TLPH 45.62
- Support Level
- MCVT $1.78
- TLPH $0.45
- Resistance Level
- MCVT $1.92
- TLPH $0.52
- Average True Range (ATR)
- MCVT 0.07
- TLPH 0.03
- MACD
- MCVT -0.01
- TLPH -0.00
- Stochastic Oscillator
- MCVT 31.25
- TLPH 35.33
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.